According to the results of a study presented at the 2007 San Antonio Breast Cancer Symposium, adjuvant chemotherapy with Taxotere® (docetaxel) and cylophosphamide results in better survival than adjuvant chemotherapy with doxorubicin and cyclophosphamide....
Read More...
[Source: Breast Cancer News]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment